Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

ChainsTypeFamily Name Domain Identifier Family IdentifierProvenance Source (Version)
BSCOP2B SuperfamilySubtilisin-like 8069727 3000226 SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
BPCSK9_C-CRD_2nde3h42B2 A: beta duplicates or obligate multimersX: Resistin (From Topology)H: Resistin (From Topology)T: ResistinF: PCSK9_C-CRD_2ndECOD (1.6)
BPCSK9_C-CRD_1ste3h42B5 A: beta duplicates or obligate multimersX: Resistin (From Topology)H: Resistin (From Topology)T: ResistinF: PCSK9_C-CRD_1stECOD (1.6)
BPCSK9_C-CRD_3rde3h42B3 A: beta duplicates or obligate multimersX: Resistin (From Topology)H: Resistin (From Topology)T: ResistinF: PCSK9_C-CRD_3rdECOD (1.6)
BPeptidase_S8e3h42B1 A: a/b three-layered sandwichesX: Subtilisin-likeH: Subtilisin-like (From Topology)T: Subtilisin-likeF: Peptidase_S8ECOD (1.6)
D [auth H]C1-set_1e3h42H2 A: beta sandwichesX: Immunoglobulin-like beta-sandwichH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: C1-set_1ECOD (1.6)
D [auth H]V-set_12e3h42H1 A: beta sandwichesX: Immunoglobulin-like beta-sandwichH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: V-set_12ECOD (1.6)
AInhibitor_I9e3h42A2 A: a+b two layersX: Alpha-beta plaitsH: Protease propeptides/inhibitors (From Topology)T: Protease propeptides/inhibitorsF: Inhibitor_I9ECOD (1.6)
C [auth L]C1-sete3h42L2 A: beta sandwichesX: Immunoglobulin-like beta-sandwichH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: C1-setECOD (1.6)
C [auth L]V-set_3e3h42L1 A: beta sandwichesX: Immunoglobulin-like beta-sandwichH: Immunoglobulin-relatedT: Immunoglobulin/Fibronectin type III/E set domains/PapD-likeF: V-set_3ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

IMGT Antibody Annotation IMGT Database Homepage

ChainProtein NameDescriptionOrganism NameGene Allele Name(s)Domain Name(s)Receptor TypeReceptor DescriptionProvenance Source
D [auth H]PCSK9 neutralizing Fab antibody VH-CH1 Homo sapiens (human) IGHV3-21*01, IGHV3-21*02, IGHV3-21*04, IGHV3-21*03, IGHJ3*01, IGHG1*01, IGHG1*02, IGHG1*04 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_LAMBDA IMGT (202447-0)
C [auth L]PCSK9 neutralizing Fab antibody L-LAMBDA Homo sapiens (human) IGLV1-40*01, IGLJ2*01, IGLJ3*02, IGLJ3*01, IGLC2*01, IGLC2*02, IGLC3*04 V-DOMAIN V-LAMBDA, C-DOMAIN C-LAMBDA IG FAB-GAMMA-1_LAMBDA IMGT (202447-0)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
D [auth H]Heavy ChainIGHV3 -proprotein convertase subtilisin/kexin type 9 | proprotein convertase subtilisin/kexin type 9SAbDab (2024-11-29)
C [auth L]Light ChainIGLV1 Lambdaproprotein convertase subtilisin/kexin type 9 | proprotein convertase subtilisin/kexin type 9SAbDab (2024-11-29)

Protein Family Annotation Pfam Database Homepage

ChainsAccessionNameDescriptionCommentsSource
PF18463Proprotein convertase subtilisin-like/kexin type 9 C-terminal domain (PCSK9_C3)Proprotein convertase subtilisin-like/kexin type 9 C-terminal domainThis entry represents a subdomain found in the C-terminal cysteine/histidine-rich domain (CRD) of PCSK9 (also known as neural apoptosis-regulated convertase, NARC-1) [1]. PCSK9 has been shown to regulate circulating LDL-R levels by controlling LDL-R ...This entry represents a subdomain found in the C-terminal cysteine/histidine-rich domain (CRD) of PCSK9 (also known as neural apoptosis-regulated convertase, NARC-1) [1]. PCSK9 has been shown to regulate circulating LDL-R levels by controlling LDL-R degradation. Furthermore, numerous mutations in the PCSK9 gene have been identified and associated with hypercholesterolemia (gain of function) or hypocholesterolemia (loss of function) [2]. The fully folded CRD, shows structural similarity to the resistin homotrimer, a small cytokine associated with obesity and diabetes. The C-terminal domain from PCSK9 consists of three, three-stranded beta-subdomains arranged in a pseudothreefold, and each of the subdomains in the CRD of PCSK9 consists of three structurally conserved disulfide bonds [1].
Domain
PF18464Proprotein convertase subtilisin-like/kexin type 9 C-terminal domain (PCSK9_C2)Proprotein convertase subtilisin-like/kexin type 9 C-terminal domainThis entry represents a subdomain found in the C-terminal cysteine/histidine-rich domain (CRD) of PCSK9 (also known as neural apoptosis-regulated convertase, NARC-1) [1]. PCSK9 has been shown to regulate circulating LDL-R levels by controlling LDL-R ...This entry represents a subdomain found in the C-terminal cysteine/histidine-rich domain (CRD) of PCSK9 (also known as neural apoptosis-regulated convertase, NARC-1) [1]. PCSK9 has been shown to regulate circulating LDL-R levels by controlling LDL-R degradation. Furthermore, numerous mutations in the PCSK9 gene have been identified and associated with hypercholesterolemia (gain of function) or hypocholesterolemia (loss of function) [2]. The fully folded CRD, shows structural similarity to the resistin homotrimer, a small cytokine associated with obesity and diabetes. The C-terminal domain from PCSK9 consists of three, three-stranded beta-subdomains arranged in a pseudothreefold, and each of the subdomains in the CRD of PCSK9 consists of three structurally conserved disulfide bonds [1].
Domain
PF18459Proprotein convertase subtilisin-like/kexin type 9 C-terminal domain (PCSK9_C1)Proprotein convertase subtilisin-like/kexin type 9 C-terminal domainThis entry represents a subdomain found in the C-terminal cysteine/histidine-rich domain (CRD) of PCSK9 (also known as neural apoptosis-regulated convertase, NARC-1) [1]. PCSK9 has been shown to regulate circulating LDL-R levels by controlling LDL-R ...This entry represents a subdomain found in the C-terminal cysteine/histidine-rich domain (CRD) of PCSK9 (also known as neural apoptosis-regulated convertase, NARC-1) [1]. PCSK9 has been shown to regulate circulating LDL-R levels by controlling LDL-R degradation. Furthermore, numerous mutations in the PCSK9 gene have been identified and associated with hypercholesterolemia (gain of function) or hypocholesterolemia (loss of function) [2]. The fully folded CRD, shows structural similarity to the resistin homotrimer, a small cytokine associated with obesity and diabetes. The C-terminal domain from PCSK9 consists of three, three-stranded beta-subdomains arranged in a pseudothreefold, and each of the subdomains in the CRD of PCSK9 consists of three structurally conserved disulfide bonds [1].
Domain
PF05922Peptidase inhibitor I9 (Inhibitor_I9)Peptidase inhibitor I9This family includes the proteinase B inhibitor from Saccharomyces cerevisiae and the activation peptides from peptidases of the subtilisin family. The subtilisin propeptides are known to function as molecular chaperones, assisting in the folding of ...This family includes the proteinase B inhibitor from Saccharomyces cerevisiae and the activation peptides from peptidases of the subtilisin family. The subtilisin propeptides are known to function as molecular chaperones, assisting in the folding of the mature peptidase [1], but have also been shown to act as 'temporary inhibitors' [2].
Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

ChainsPolymerMolecular FunctionBiological ProcessCellular Component
Proprotein convertase subtilisin/kexin type 9
D [auth H]Fab from LDLR competitive antibody: Heavy chain---
Proprotein convertase subtilisin/kexin type 9
C [auth L]Fab from LDLR competitive antibody: Light chain---

Pharos: Disease Associations Pharos Homepage Annotation

ChainsDrug Target  Associated Disease
PharosQ8NBP7
PharosQ8NBP7